Medicorp Pharmaceuticals India Profile
Key Indicators
- Authorised Capital ₹ 12.00 Cr
as on 08-07-2024
- Paid Up Capital ₹ 5.38 Cr
as on 08-07-2024
- Company Age 31 Year, 7 Months
- Last Filing with ROC 31 Mar 2022
- Revenue %
(FY 2017)
- Profit 55.72%
(FY 2017)
- Ebitda 55.72%
(FY 2017)
- Net Worth -0.05%
(FY 2017)
- Total Assets -0.00%
(FY 2017)
About Medicorp Pharmaceuticals India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 12.00 Cr and a paid-up capital of Rs 5.38 Cr, as per Ministry of Corporate Affairs (MCA) records.
Raghunath Dash, Srivatsan, and Vijayaraghavan Seshadri serve as directors at the Company.
- CIN/LLPIN
U24231TN1993PTC025019
- Company No.
025019
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 May 1993
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Medicorp Pharmaceuticals India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srivatsan  | Director | 01-Aug-2020 | Current |
| Raghunath Dash | Additional Director | 02-Mar-2020 | Current |
| Vijayaraghavan Seshadri | Additional Director | 29-May-2019 | Current |
Financial Performance of Medicorp Pharmaceuticals India.
Medicorp Pharmaceuticals India Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 55.72% increase in profit. The company's net worth dipped by a decrease of 0.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medicorp Pharmaceuticals India?
In 2017, Medicorp Pharmaceuticals India had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medicorp Pharmaceuticals India?
Unlock and access historical data on people associated with Medicorp Pharmaceuticals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medicorp Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medicorp Pharmaceuticals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
